Utility of lung density measurements in the diagnosis of emphysema  by Marsh, Suzanne et al.
ARTICLE IN PRESS
Respiratory Medicine (2007) 101, 1512–15200954-6111/$ - see fr
doi:10.1016/j.rmed.
Corresponding au
fax: +64 4 472 9224.
E-mail address: RUtility of lung density measurements in the diagnosis
of emphysema
Suzanne Marsha, Sarah Aldingtona, Mathew V. Williamsa, Michael R. Nowitzb,
Andrew Kingzett-Taylorb, Mark Weatherallc, Philippa M. Shirtcliffea,
Amanda A. McNaughtona, Alison Pritcharda, Richard Beasleya,d,aMedical Research Institute of New Zealand, P.O. Box 10055, Wellington, New Zealand
bPaciﬁc Radiology Limited, Wellington, New Zealand
cWellington School of Medicine & Health Sciences, Wellington, New Zealand
dUniversity of Southampton, Southampton, UK
Received 5 October 2006











Background: The role of computerised tomography (CT) lung density measurements in
objective quantiﬁcation of emphysema is uncertain. The aim of this study was to
determine normal reference values for CT lung density measurements and investigate their
utility in identifying subjects with clinical emphysema.
Methods: Normal subjects (non-smokers, no respiratory disease, n ¼ 185) and subjects
with clinical emphysema (post-bronchodilator FEV1/FVC o70%, X10 pack years tobacco
smoking, no childhood asthma and, either DLCO/VA o80% predicted and/or macroscopic
emphysema on CT, n ¼ 22) were identiﬁed from a random population survey. Subjects
underwent CT scanning, with measurement of areas of low attenuation as a percentage of
total area (RA%) for three standardised slices and two reconstruction algorithms with a
density threshold of 950HU. Reference values in normal subjects, and ability of the
measurements to discriminate between the two groups were determined.
Results: Reference values for individual subjects showed wide conﬁdence intervals
(standard resolution scans, RA% females 0.2–3.9%, males 0.4–8.7%.) Subjects with
emphysema had greater RA% values compared with normal subjects, the difference being
most marked in apical slices (standard resolution algorithm, apical slice, median RA% 2.9%
(95% CI 0.4–11.1%) vs. 0.1% (95% CI 0.0–0.5%), emphysema vs. normal subjects,
respectively). Logistic regression analysis showed poor discriminant ability to distinguish
between the groups, the most favourable cut-off yielding a sensitivity and speciﬁcity of
83.3% and 62.8%, respectively.Published by Elsevier Ltd.
arch Institute of New Zealand, P.O. Box 10055, Wellington, New Zealand. Tel.: +64 4 472 9199;
rinz.ac.nz (R. Beasley).
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Lung density measurements in emphysema 1513Conclusions: CT lung density measurements cannot reliably detect the presence of
emphysema in an individual. We recommend further investigation into lung density
measurements before their widespread use in clinical practice.
& 2007 Published by Elsevier Ltd.Introduction
Emphysema is a histological diagnosis characterised by the
‘‘abnormal permanent enlargement of the airspaces distal
to the terminal bronchioles, accompanied by destruction of
their wallsy’’.1 Physiologically it is recognised as a
condition comprising largely irreversible airﬂow obstruction
with a signiﬁcant reduction in diffusing capacity.2 Radiology
provides in vivo assessment of emphysema with compu-
terised tomography (CT) scanning being superior to standard
chest radiography in identifying macroscopic emphysema.3
Subjective quantiﬁcation of emphysema on CT has been
correlated with pathological ﬁndings by a number of
authors4,5 but objective quantiﬁcation with measurement
of areas of abnormally low attenuation offers potential
advantages in terms of accuracy and elimination of inter-
observer variability.6,7
The potential of lung density measurements to diagnose
emphysema in vivo was ﬁrst noted by comparison of
frequency distribution curves of density measurements
between those with and without subsequent pathological
diagnoses of emphysema.8 Density threshold techniques use
a computer program to identify the percentage of total lung
area occupied by areas of low attenuation (the radiological
equivalent of tissue loss) below a predetermined value.3 The
original study using this technique used a threshold of 910
Hounsﬁeld Units (HU)9 whilst subsequent workers used
950HU,10,11 both measurements showing a close correla-
tion with pathological features of emphysema. These
techniques have subsequently been used in studies of a1-
antitrypsin deﬁciency12–14 and it has been suggested that
lung density measurements represent a new ‘‘gold stan-
dard’’ for clinical trials of this condition.15
The availability of a method to detect emphysema in vivo
amongst those at risk has intuitive appeal. It has been
proposed that low-density measurements representing more
than a few percent of total lung area can be used as a cut off
to discriminate between normal and emphysematous
lungs.11 Other authors, however, have reported a wide
range of values in small samples of normal subjects.16
Furthermore, we have recently shown that the relative area
of low attenuation predominantly correlates with measures
of hyperinﬂation and airﬂow obstruction, rather than gas
transfer.17 Thus, there is a need to both determine
reference ranges for lung density measurements and the
ability of these measurements to discriminate between
normal subjects and those with emphysema.
In this study, the normal range for CT density measure-
ments in subjects who were never smokers with no diagnosis
of respiratory disease, no current respiratory symptoms andno inhaled medication use was determined. Normal refer-
ence values were derived utilising a density threshold of
950HU and two reconstruction algorithms (high and low
spatial frequency). Comparison of CT density between
normal subjects and those with a clinical diagnosis of
emphysema was made and the ability of lung density




Study participants (aged 25–75 years) were randomly
selected from the electoral register and recruited using a
postal questionnaire. Those completing the postal survey
were invited to undertake a detailed interviewer adminis-
tered questionnaire followed by respiratory function testing
and a CTscan of the chest. The Wellington Ethics Committee
approved the study and written informed consent was
obtained from each subject.
To be included as a ‘normal subject’ in this study,
participants had to be never smokers, have no diagnosis of
a respiratory disease, no current respiratory symptoms and
no use of inhaled medication. Subjects with ‘clinical
emphysema’ were selected from those fulﬁlling the GOLD
criteria for COPD18 (post-bronchodilator forced expiratory
volume in 1 s (FEV1)/forced vital capacity (FVC) ratio of
o70%) and were required to have at least 10 pack years of
cigarette smoking, no doctor’s diagnosis of asthma prior to
the age of 18 years and, either a diffusing capacity
corrected for lung volume (DLCO/VA) of o80% of predicted
and/or macroscopic emphysema on CT scan. Subjects
fulﬁlling the criteria for the two diagnostic groups were
selected from all those who had completed respiratory
function tests and a CT scan (Fig. 1).
Pulmonary function testing
Pulmonary function tests were carried out using two Jaegar
Master Screen Body volume constant plethysmography units
with pneumotachograph and diffusion unit (Masterlab 4.5
and 4.6 Erich-Jaegar, Wurzburg, Germany) by trained
operators (SA, SM, MVW). Equipment was calibrated daily,
prior to testing. Subjects were instructed not to use short-
acting bronchodilators for 6 h and long-acting bronchodila-
tors for 36 h prior to testing. Inhaled corticosteroids or other
medication was not altered. Subjects were required not to





FEV1/FVC <70%, n=118 
Never tobacco smoker
n=370
No asthma prior to age 18
n=95
Never pipe or cigar smoker and
<20 marijuana cigarettes (ever),
n=330 
Smoker >10 pack years
n=47
No doctor diagnosis of respiratory
disease*
n=229
DLCO/VA < 80% and/or CT
macroscopic emphysema
n=22




No sputum/cough >3 months
each year,
n=191
















Figure 1 Selection criteria for study groups. Flow diagram
showing the criteria used to deﬁne the ‘normal’ subjects and
those with emphysema from the starting population of 739
subjects. The numbers at each stage of the ﬂow diagram
indicate the number of subjects remaining following application
of each criterion in the process to identify the two study groups.
*Asthma, chronic bronchitis, emphysema, COPD or bronchiec-
tasis.
S. Marsh et al.15143 weeks of an upper or lower respiratory tract infection
(new or increased cough, sputum production, sore throat or
nasal congestion).
Tests included measurement of FEV1, FVC, residual
volume (RV), total lung capacity (TLC) and diffusing capacity
(DLCO). Diffusing capacity was corrected for lung volume by
dividing by measured alveolar volume (VA) and adjusted for
haemoglobin concentration. All measurements were carried
out in accordance with American Thoracic Society (ATS) and
European Respiratory Society (ERS) guidelines.19–21
Measurements of lung volumes and spirometry were
repeated 45min after the administration of 400mcg of
Salbutamol (VentolinTM GlaxoSmithKline) via a spacer (Space
ChamberTM). Results were corrected to BTPS and expressed
as a percentage of predicted based on locally derived
formulae22 except for FEV1/FVC, which was expressed as an
absolute ratio.CT scanning
Subjects were scanned using a single machine, (GE
Prospeed, General Electric Medical Systems, YMS, Japan)
calibrated at weekly intervals using the manufacturers
standard phantom. Scans were obtained at full inspiration
and no intravenous contrast was used. An initial ‘scout ﬁlm’was used to identify the levels at which to acquire images.
Three images were obtained, one at each of the levels of
1 cm above the aortic arch (level 1), 1 cm below the carina
(level 2) and 3 cm above the top of the right hemi-diaphragm
(level 3)23 with 1mm collimation, voltage of 120 kVp,
200mA s. Scanning occurred in a cranial to caudal direction
with each image obtained during a separate breath hold
each of 1.5 s duration. Images were reconstructed using high
(GE bone) and low spatial frequency (GE standard) resolu-
tion algorithms and the manufacturer’s ‘Density Mask’
program used to measure tissue density. Trachea and
mainstem bronchi were excluded from the measurements
of lung area and lung tissue was separated from chest wall
using a density of 300 to 1200HU to calculate the total
area of lung tissue per slice. The areas of tissue below the
threshold of 950HU was expressed as a percentage of total
lung area for that slice (RA950).
Scans were independently examined for the presence of
emphysema by two radiologists (MN, AKT), blinded to
the subjects’ clinical history. The radiological diagnosis of
emphysema was made if centrilobular low-density areas,
panlobular or paraseptal emphysematous changes were
present, and subjects were graded as having no
evidence of emphysema, changes suggestive of emphysema,
or deﬁnite emphysema. In cases of discordance, the
images were viewed together and a consensus decision
reached. Only subjects with ‘deﬁnite’ emphysema were
included as having macroscopic disease in subsequent
analyses.Statistical analysis
Simple descriptive statistics, t-tests and chi-squared test for
proportions, were used to describe subject characteristics
and lung density estimates for normal subjects and those
with emphysema. The relationship between lung density,
age and gender in the normal group was explored, using
plots, simple correlation coefﬁcients and where appropriate
linear regression. Linear regression was used to predict CT
density measurements by gender. Normality assumptions
were not well met for the untransformed lung density data,
as might be anticipated since values are expressed as
proportions, and the data was skewed. The logit transfor-
mation, which is the natural logarithm of the ratio of the
proportion to 1 minus the proportion (i.e. the odds), met
normality assumptions. Once the predicted values and their
conﬁdence intervals were calculated using the transformed
variables the inverse transformation was used to calculate
those values on the original scale. The difference in lung
density measurements by emphysema status was tested by
the Mann–Whitney U-test, together with appropriate con-
ﬁdence intervals. Box plots of the logit transformation of
the lung density measurements were presented. Logistic
regression was used to generate receiver operating char-
acteristic (ROC) curves to examine the potential discrimina-
tion between normal subjects and subjects with
emphysema. These curves were summarised by the area
under the curve, the ‘c’ statistic. Values of this statistic
close to 0.5 mean discrimination is poor and close to one
that discrimination is excellent. SAS version 9.1 and Minitab
version 14.2 were used for the analyses.
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Initial recruitment resulted in 2319 responses from 3500
postal questionnaires. With the exclusion of 508 subjects
unable to be traced from the address on the electoral
register and 13 subjects who had died, this represented a
response rate of 2319/2979 (78%). Of those subjects
completing the postal questionnaire, 758 completed the
detailed questionnaire and pulmonary function tests. Of
these 739 (97%) undertook CT scanning.
Table 1 shows the characteristics of the subjects included
in each of the two groups. There were 185 subjects in the
‘‘normal’’ group and 22 subjects in the ‘‘emphysema’’ group
(11 macroscopic emphysema, 19 abnormal DLCO/VA, 8 both).
The subjects with emphysema were older, more likely to be
male and had smoked on average 39 pack years of tobacco
with 12 being current and 10 being ex smokers. The mean
post-bronchodilator FEV1 in this group was 69% of predicted
normal values. When classiﬁed according to the GOLD
severity criteria,18 there were 6, 12, 2 and 2 subjects with
mild (Stage 1, FEV1 480% predicted), moderate (Stage 2,
FEV1 50–80% predicted), severe (Stage 3, FEV1 30–50%
predicted) and very severe (Stage 4, FEV1 o30% predicted)
disease respectively. There were signiﬁcant differences
between the emphysema and normal groups for all listed
characteristics (P ¼ 0:001 for the proportion of males and
Po0:0001 for age and lung function) in Table 1.
Of the subjects in the normal group all had scans assessed
using the high-resolution reconstruction, whilst 156 were
assessed with both the high and low spatial frequency
(standard) resolution algorithms. In the emphysema
group the corresponding ﬁgures were 22 with high-resolution
reconstruction and 18 subjects assessed with both
algorithms.
Descriptive statistics for lung density measurement by
diagnostic group are shown in Table 2. For the high-
resolution reconstruction, the range of RA950 values were
wide in both diagnostic groups. This was also seen with the
standard resolution reconstruction although the variation
was less marked in normal subjects. For both high














FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; RV:
for carbon monoxide; VA: alveolar volume.considerable degree of overlap between the diagnostic
groups (Figs. 2 and 3). In normal subjects RA% values were
lower in the apical, compared with mid and lower slices.
Reference ranges for lung density measurements in the
normal group, by sex, are shown in Table 3. These are based
on a linear regression on the logit transformation of the lung
density, with an inverse transformation back to the original
scale of measurement. We used the mean of three slices as
the response variable as there was a very high correlation
(analysis not shown) between the values for each slice
within individuals. Both the conﬁdence interval for the
mean for each sex and the interval for an individual
prediction for each sex are shown.
Although in the normal subjects lung density measure-
ments were related to sex for all thresholds and algorithms
this was not due to differences in TLC. Analysis by simple
plots suggested a weak relationship between lung density
and age in the normal group, with only the high resolution
scans showing a consistent correlation with all slices. This
showed a very small decrease in lung density (increase in
RA% below 950HU) with increasing age conﬁrmed by
analysis of covariance with a slope parameter for age, using
the untransformed values, of 0.086 (95% CI 0.02–0.15,
P ¼ 0:02).
There was a strong association between the presence of
macroscopic emphysema and lung density expressed as a
mean of the three slices (data not shown). For both standard
and high-resolution reconstructions RA950 values were
signiﬁcantly higher in those with emphysema than in the
normal group, the difference being most marked in apical
slices (Table 2). However, none of the different slices or
algorithms gave useful discrimination between the groups
when subjected to logistic regression analysis, which was
used to construct ROC curves (Table 4).
The apical slice measurement in the standard resolution
scan showed better discrimination between the groups than
other slices, as denoted by the ‘c’ statistic. However, even for
this slice discrimination was poor with the best RA% cut-off
value of 0.27% having a sensitivity of 83.3% (15/18 correctly
classiﬁed as emphysema) and a speciﬁcity of 62.8% (98/156
correctly classiﬁed as not having emphysema) (Fig. 4).ormal N ¼ 185 Emphysema N ¼ 22
(%) N (%)
88 (47.6) 19 (86.4)
ean (SD)
54.4 (12.6) 64.7 (5.9)
on-smokers 39.2 (18.9)
79.6 (6.6) 56.6 (10.2)
97.8 (12.8) 63.7 (20.9)
01.0 (12.7) 68.8 (20.7)
99.6 (17.9) 156.2 (57.2)
99.4 (9.7) 111.6 (12.8)
99.4 (11.9) 65.9 (12.7)
00.7 (10.9) 68.1 (10.9)
residual volume; TLC: total lung capacity; DLCO: transfer factor
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Table 2 Description of CT density readings (RA%) by algorithm and slice.
Normal Emphysema Emphysema minus
normal (95% CI)
P-value
High resolution N ¼ 185 N ¼ 22
Slice 1 12.9 23.3 9.4
Median (IQR) (8.4–17.5) (14.9–28.4) (4.9–13.6) 0.0001
Slice 2 16.2 21.0 6.6
Median (IQR) (10.8–21.4) (16.3–28.6) (2.8–10.5) 0.0007
Slice 3 15.6 23.3 6.6
Median (IQR) (10.1–21.0) (16.1–27.2) (3.3–9.8) 0.0002
Mean of 3 slices 15.0 23.1 8.0
Median (IQR) (9.9–20.1) (17.4–28.1) (4.6–11.4) o0.0001
Standard resolution N ¼ 156 N ¼ 18
Slice 1 0.1 2.9 2.6
Median (IQR) (0.0–0.5) (0.4–11.1) (0.7–4.4) o0.0001
Slice 2 0.1 5.1 3.0
Median (IQR) (0.5–2.9) (2.0–11.1) (1.2–5.7) 0.0003
Slice 3 2.5 7.0 4.2
Median (IQR) (1.1–4.4) (3.7–15.1) (2.0–6.8) o0.0001
Mean of 3 slices 1.4 6.2 4.4
Median (IQR) (0.6–2.9) (2.3–11.6) (2.2–6.6) o0.0001
Slice 1: 1 cm above the aortic arch; Slice 2: 1 cm below the carina; Slice 3: 3 cm above the top of the right hemi-diaphragm.
The Mann–Whitney U test was used to compare the difference between density measurements in normal and emphysematous
subjects.
S. Marsh et al.1516Discussion
This study has shown that subjects with emphysema had
signiﬁcantly higher relative areas occupied by lung tissue
with low attenuation when compared to subjects with no
respiratory disease. However, the wide range of results seen
across the two diagnostic categories indicated that it was
not possible to use lung density measurements alone to
determine the presence or absence of emphysema in
individual subjects. This suggests that whereas CT lung
density measurements may be informative in quantifying
emphysema in research, they are unlikely to be useful in
clinical practice for the purpose of identifying which
subjects with COPD have coincident emphysema.Methodological issues
A limited three-slice CT scan protocol was used due to
evidence that three slices gives information comparable to a
more detailed 10-slice protocol even in the heterogenous
distribution of emphysema seen in COPD.23 This protocol
also kept radiation exposure to a minimum. A 1mm
collimation was used since this has shown close association
between lung density measurements and emphysema at
both the macroscopic and microscopic level10,11 although
there is recent evidence to suggest thicker CT slices may be
preferable to smaller collimations.24 Inspiratory scans have
been shown to be superior to expiratory scans whencompared to pathological measurements of emphysema25
and scans taken as close as possible to TLC have recently
been recommended for longitudinal follow-up of emphyse-
ma.26 Although, correction of lung density measurement for
the lung volume at which the scan was obtained may be
necessary in serial scans27 such adjustments are not
recommended in cross sectional studies such as this.28
We chose to use 950HU as a density threshold, since this
has been shown to correlate closely with the pathological
extent of emphysema as well as pulmonary function tests of
airﬂow obstruction and gas transfer.10,11 The high-resolution
algorithm consistently produced higher RA% values than the
standard resolution algorithm conﬁrming previous work
regarding the effect of reconstruction algorithms29 and
extending this observation to the 950HU threshold. Based
on the work of Gevenois et al.,10,11 we initially used high
resolution reconstruction algorithms. However, due to the
evidence that standard resolution algorithms may be
preferable for assessing lung density,26–30 the protocol was
amended to include this analysis. Data were also analysed
with the 910HU threshold, using both high and standard
resolution reconstructions. However, this resulted in worse
discrimination between the emphysema and normal groups
than the 950HU threshold. Another approach would have
been to use the percentile density method; however, it has
not been established which percentile provides the best
determinant of emphysema.31–33
Recent work using soft tissue kernel reconstruction, thin






































































Figure 2 Box plots of the logit of the proportion of lung with low density (as RA%) by slice for high-resolution scans and threshold of
950HU. *HR: High resolution. The central line in each plot represents the median and the ends of the boxes are the inter-quartile
boundaries. The whiskers extend to the data point closest to the inner fence (1.5 the inter-quartile range) and data points outside
the inner fence are highlighted. Slice 1: 1 cm above the aortic arch; Slice 2: 1 cm below the carina; Slice 3: 3 cm above the top of the
right hemi-diaphragm; Mean: mean measurement for all 3 slices.
Lung density measurements in emphysema 1517need for standardisation in the ﬁeld of quantitative density
measurement.34 It is evident that these different CT
scanning techniques encompassing recent technological
advances will result in a differing utility in identifying
subjects with emphysema. However, this consideration does
not reduce the signiﬁcance of our ﬁndings, which are based
on the CT methodology that had been established following
extensive validation at the time our study was planned.
The clinical deﬁnition of emphysema employed was
restrictive in an attempt to make the diagnosis as speciﬁc
as possible. For example, subjects who had been heavy
tobacco smokers and otherwise met the criteria for
emphysema were excluded if they had a history of childhood
asthma; subjects with ﬁxed airﬂow obstruction were not
included unless deﬁnite macroscopic changes of emphysema
on CT scanning or low diffusing capacity corrected for lung
volume were also seen. The requirement for a reduced
DLCO/VA was made since of all physiological markers this
correlates most closely with the presence of pathological
features of emphysema.11 As a result, these criteria ensured
high speciﬁcity for the diagnosis of emphysema which was
crucial for the analyses undertaken.
One important consideration was whether the poor
discrimination between the groups might have been due to
predominantly mild disease in those with emphysema, inwhich marked changes in lung density may not be expected.
However, as a group, these subjects had moderately severe
obstructive airways disease assessed according to GOLD
criteria18 with a mean post-bronchodilator FEV1 of 69%
predicted. In addition the requirement for either macro-
scopic emphysema or a signiﬁcantly reduced diffusing
capacity indicated that the emphysema group had clinically
signiﬁcant disease.Density measurements in normal subjects and the
effect of age and gender
We observed a wide range of densitometry readings in
‘normal’ subjects without a history of respiratory disease or
previous smoking. This ﬁnding is consistent with the study of
Gevenois et al.35 in which a range of RA950 values of
between 1.2% and 23.3% were reported. Similarly, Mishima
et al.36 reported that the percentage of low attenuation
levels o960HU occupying a lung ﬁeld was up to 30% in
healthy subjects. Therefore although it has been suggested
that for the high resolution algorithm an RA950 limit of 6.8%
could distinguish subjects with and without emphysema11
our results have conﬁrmed that many normal subjects have

































































Figure 3 Box plots of the logit of the proportion of lung with low density (RA%) by slice for standard resolution scans and threshold
of 950HU. *STD: Standard resolution. The central line in each plot represents the median and the ends of the boxes are the inter-
quartile boundaries. The whiskers extend to the data point closest to the inner fence (1.5 the inter-quartile range) and data points
outside the inner fence are highlighted. Slice 1: 1 cm above the aortic arch; Slice 2: 1 cm below the carina; Slice 3: 3 cm above the
top of the right hemi-diaphragm; Mean: mean measurement for all 3 slices.
S. Marsh et al.1518determine 95% conﬁdence intervals for RA values for the
normal subjects dependent on reconstruction algorithm
although these may have limited clinical relevance given
the wide overlap with values seen in those with emphysema.
Our results suggest that the effect of age on lung density
measurements is small. This is in keeping with other studies
although there have been conﬂicting results regarding this
relationship. Gevenois et al.35 found a small but signiﬁcant
relationship between RA950 and age and postulated that
this could reﬂect an increase in airspace size with aging as
shown by Gillooly and Lamb.37 Others, however, have shown
no association between lung density measurements and
age.38,39 In the only longitudinal study of density measure-
ments in normal subjects Soejima et al.40 showed an
increase over 5 years in the percentage of low attenuation
areas in middle and lower lung slices of around 1% per
annum in subjects aged over 50.
We observed that gender had a signiﬁcant effect on density
measurements, not accounted for by differences in lung
volume. Studies involving subjects undergoing surgery for
lung malignancy or emphysema have predominantly included
male subjects9–11 and few have commented on the possible
effect of gender. One study35 found that median values for
RA950 were not signiﬁcantly different between male andfemale subjects but did ﬁnd a signiﬁcant correlation between
TLC and RA950. Males have larger lung capacities than
females, however when adjustment was made to take
account of this, the difference between the sexes persisted
in our study. However, to put this in perspective the
combination of age and gender alone explained only 15% of
variance in lung density measurements.Ability of density measurements to identify subjects
with emphysema
The main ﬁnding of the study was that although the
emphysema group had signiﬁcantly higher RA% values
compared with healthy subjects, there was a considerable
degree of overlap between these two groups. Formal testing
of the discriminatory ability of lung density measurements
showed that this method did not accurately discriminate
between healthy subjects and those with clinical emphyse-
ma. Although there is no set value for the area under a
receiver operator characteristics curve which distinguishes
between a ‘good’ and ‘bad’ discriminatory test, our ﬁndings
show that by any standard, discrimination was poor with
values less than 0.8 for nearly all slices and algorithms.
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Table 3 Predicted values (RA%) for lung density measurements as a mean of three slices based on sex.





Male 15.8 14.4–17.4 6.2–34.8
Female 11.1 10.1–12.1 4.2–26.1
Standard resolution
Male 1.9 1.6–2.3 0.4–8.7
Female 0.8 0.7–1.0 0.2–3.9
Predicted relative area % occupied by tissue below 950HU based on the mean value of three slices.
Table 4 Area under the receiver operating character-
istic curve (‘c’ statistic) for different slices and algo-
rithms to discriminate emphysema from normal.
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Figure 4 Receiver operator characteristics (ROC) plot for the
apical slice of the standard resolution scan at a threshold of
950HU. At an RA% value of 0.274 the sensitivity and speciﬁcity
for detecting emphysema were 83.3% (15/18 correctly classiﬁed
as emphysema) and 62.8% (98/156 correctly classiﬁed as not
having emphysema), respectively.
Lung density measurements in emphysema 1519Apical CT slices showed the greatest differences between
those with emphysema and healthy subjects, consistent
with the previous report that upper lung slices have the
greatest ability to distinguish smokers from non-smokers.40
This is presumably due to emphysema (in smokers without a1
antitrypsin deﬁciency) occurring predominately (at least
initially) in the upper lobes.1 This suggests that in research
utilising lung density measurements to quantify emphysema,
an apical standard resolution scan utilising the 950HU
threshold is currently the preferred measurement.
With advances in CT technology, new methods of
measuring lung density will undoubtedly be developed. For
the application of such novel methods to both research and
clinical practice it will be essential that normal reference
ranges are determined, and that the discriminant ability of
the measurements to identify subjects with emphysema is
established.34
In conclusion, we have deﬁned normal reference values
for CT lung density measurements in an adult population and
shown that subjects with emphysema have a signiﬁcantly
higher relative area occupied by lung tissue with low
attenuation than subjects without respiratory disease.
However, with the validated methodology used in this study,
CT lung density measurements alone could not reliably be
used to detect the presence of emphysema in an individual.
We recommend further investigation into lung density
measurement before its widespread clinical use to screen
for or diagnose emphysema.Acknowledgements
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